- Home
- BATL vs AIFF Comparison
BATL vs AIFF Comparison
Compare BATL & AIFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BATL
- AIFF
- Stock Information
- Founded
- BATL 1987
- AIFF 2006
- Country
- BATL United States
- AIFF Canada
- Employees
- BATL N/A
- AIFF N/A
- Industry
- BATL Oil & Gas Production
- AIFF
- Sector
- BATL Energy
- AIFF
- Exchange
- BATL Nasdaq
- AIFF NYSE
- Market Cap
- BATL 29.9M
- AIFF 26.6M
- IPO Year
- BATL N/A
- AIFF N/A
- Fundamental
- Price
- BATL $1.47
- AIFF $4.11
- Analyst Decision
- BATL
- AIFF
- Analyst Count
- BATL 0
- AIFF 0
- Target Price
- BATL N/A
- AIFF N/A
- AVG Volume (30 Days)
- BATL 56.9K
- AIFF 955.6K
- Earning Date
- BATL 05-14-2025
- AIFF 05-21-2025
- Dividend Yield
- BATL N/A
- AIFF N/A
- EPS Growth
- BATL N/A
- AIFF N/A
- EPS
- BATL N/A
- AIFF N/A
- Revenue
- BATL $193,893,000.00
- AIFF $74,000.00
- Revenue This Year
- BATL N/A
- AIFF N/A
- Revenue Next Year
- BATL N/A
- AIFF N/A
- P/E Ratio
- BATL N/A
- AIFF N/A
- Revenue Growth
- BATL N/A
- AIFF N/A
- 52 Week Low
- BATL $1.05
- AIFF $1.86
- 52 Week High
- BATL $7.08
- AIFF $17.20
- Technical
- Relative Strength Index (RSI)
- BATL 56.10
- AIFF 46.25
- Support Level
- BATL $1.12
- AIFF $3.65
- Resistance Level
- BATL $1.34
- AIFF $5.87
- Average True Range (ATR)
- BATL 0.12
- AIFF 0.71
- MACD
- BATL 0.05
- AIFF -0.02
- Stochastic Oscillator
- BATL 93.02
- AIFF 25.30
About BATL Battalion Oil Corporation
Battalion Oil Corp is an independent oil and gas producer operating exclusively in the Delaware Basin. It is an independent energy company focused on the acquisition, production, exploration, and development of onshore liquids-rich oil and natural gas assets in the United States. The company operates in one segment which focuses on oil and natural gas acquisition, production, exploration, and development.
About AIFF FIREFLY NEUROSCIENCE INC
Firefly Neuroscience Inc is an AI company developing innovative neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support better outcomes for people suffering from mental illnesses and cognitive disorders.